Fatih M. Uckun

Illinois CNST Annual Nanotechnology Workshop 2010 Lecture 5: Nanoparticles against B–lineage Acute Lymphoblastic Leukemia

Fatih M. Uckun, 2011 .

Leveraging structure-based rational drug design and nanotechnology to destroy leukemic stem cells

Jianjun Cheng, Fatih M. Uckun, Cheney Mao, 2014 .

Structure-Based Design of Novel Dihydroalkoxybenzyloxopyrimidine Derivatives as Potent Nonnucleoside Inhibitors of the Human Immunodeficiency Virus Reverse Transcriptase

Rakesh Vig, Fatih M. Uckun, F. Uckun, 1998, Antimicrobial Agents and Chemotherapy.

STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress

Hong Ma, Fatih M. Uckun, Sanjive Qazi, 2010, Proceedings of the National Academy of Sciences.

Bruton’s Tyrosine Kinase as an Inhibitor of the Fas/CD95 Death-inducing Signaling Complex*

Fatih M. Uckun, Zahide Ozer, Alexei Vassilev, 1999, The Journal of Biological Chemistry.

Specificity of α-Cyano-β-Hydroxy-β-Methyl-N-[4-(Trifluoromethoxy)Phenyl]-Propenamide as an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase

Xiao Jun, Sutapa Ghosh, Fatih M. Uckun, 1999 .

Transcription Factor STAT5A Is a Substrate of Bruton's Tyrosine Kinase in B Cells*

Fatih M. Uckun, A. Vassilev, F. Uckun, 2001, The Journal of Biological Chemistry.